The Hague (AP): South Africa launched a case Friday at the United Nations' top court accusing Israel of genocide against Palestinians in Gaza and asking the court to order Israel to halt its attacks. Israel swiftly rejected the filing "with disgust."

South Africa's submission to the International Court of Justice alleges that "acts and omissions by Israel ... are genocidal in character" as they are committed with the intent "to destroy Palestinians in Gaza" as a part of the broader Palestinian national, racial and ethnic group.

It also asks the Hague-based court to issue an interim order for Israel to immediately suspend its military operations in Gaza. A hearing into that request is likely in the coming days or weeks. The case, if it goes ahead, will take years.

The Israeli government "rejected with disgust" the South African genocide accusations, calling it a "blood libel." A Foreign Ministry statement said the case lacks a legal foundation and constitutes a "vile exploitation and cheapening" of the court.

Israel also accused South Africa of cooperating with Hamas who attacked southern Israel on Oct. 7 triggering the ongoing war in Gaza.

The statement also said Israel is committed to and operates according to international law and focuses its military actions solely against Hamas, adding that the residents of Gaza are not an enemy. It asserted that it takes steps to minimize harm to civilians and to allow humanitarian aid to enter the territory.

South Africa can bring the case under the Genocide Convention because both it and Israel are signatories to the convention.

Whether it will succeed in halting the war remains to be seen. While the court's orders are legally binding, they are not always followed.

In March 2022, the court ordered Russia to halt hostilities in Ukraine, a binding legal ruling that Moscow flouted as it pressed ahead with its devastating attacks on Ukrainian towns and cities.

South Africa has been a fierce critic of Israel's military campaign in Gaza. Many including President Cyril Ramaphosa have compared Israel's policies in Gaza and the West Bank with South Africa's past apartheid regime of racial segregation.

Ramaphosa has accused Israel of war crimes and acts "tantamount to genocide."

Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.



Mangaluru: Kasturba Medical College (KMC) has filed a patent application for “Absorbent Pads” designed to address urinary incontinence among elderly women, a condition that remains largely underreported despite its widespread impact.

Urinary incontinence does not command urgency like a heart attack, nor does it evoke the same collective response as more visible illnesses. However, for those living with it, the burden is constant, intimate, and often isolating.

There is a gradual and often unspoken impact on daily life. It begins with hesitation, declining invitations, avoiding travel, and choosing silence over conversation. Over time, this can lead to withdrawal, where fear of embarrassment starts shaping everyday decisions. For many elderly women, dignity becomes tied to small, often invisible compromises, including limiting outings or adjusting routines.

What makes this condition particularly poignant is not just its prevalence, but its invisibility. It is endured, not expressed. Accepted, not addressed.

It is in this context that the recent innovation assumes importance. The team at KMC, which includes clinicians such as Dr Haroon Hussain, has approached the issue not merely from a technical standpoint but from the perspective of lived experience.

The proposed solution, biodegradable, antimicrobial absorbent pads with improved fluid control and reduced irritation, aims to go beyond basic functionality, addressing comfort, safety, and dignity.

The development also reflects the role of academic institutions in addressing everyday health challenges. When research focuses not only on major diseases but also on conditions that affect quality of life, it reinforces the broader purpose of healthcare.

However, experts note that innovation alone cannot fully address the issue. Urinary incontinence continues to be underreported, often dismissed as an inevitable consequence of ageing. Many women do not seek medical help, not due to a lack of solutions, but because of stigma and discomfort associated with discussing the condition.

This creates a paradox, a widespread issue that is often experienced in isolation.

Medical professionals emphasise that greater awareness and open conversations are essential. Families must learn to speak about such issues without embarrassment. Healthcare providers must create spaces where patients feel heard without judgment.

The significance of this innovation lies not only in its technical aspects but also in what it brings into focus, that even the most private discomforts deserve public attention.

The patent application was filed by a team comprising Dr. Haroon Hussain, Dr. Sameena, Dr. Ritu Raval of Manipal Institute of Technology, Syed Ayaan Hussain Rizvi, and Suzanne Riya Dsouza.